PDLI Financial Facts

Total revenues: 110.14M
Interest and other expense: -6.7M
See Full Income Statement

Convertible notes payable: 0
Cash and cash equivalents: -658.96M
See Full Balance Sheet

PDL BioPharma, Inc. (PDLI) Earnings

  |   Expand Research on PDLI
Next EPS Date N/A EPS Growth Rate +4.0%
Average EPS % Beat Rate +1.4% Revenue Growth Rate -7.0%
Average % Move 1-Wk after EPS +1.7% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/3/14 Q413 $0.39$0.43 -$0.04$110.1M$115.22M N/A -2.1% Details
11/6/13 Q313 $0.36$0.37 -$0.01$97.3M$97.09M N/A +1.2% Details
8/8/13 Q213 $0.62$0.54 +$0.08$143.6M$138.2M N/A +4.1% Details
5/9/13 Q113 $0.36$0.35 +$0.01$91.8M$91.69M N/A +7.2% Details
3/1/13 Q412 $0.34$0.32 +$0.02$86M$86.08M N/A +23% Details
11/5/12 Q312 $0.32$0.30 +$0.02$85.2M$85.03M N/A +10% Details
8/2/12 Q212 $0.53$0.49 +$0.04$125.9M$125.14M N/A +26.6% Details
5/3/12 Q112 N/A$0.26 N/A N/A$77.47M N/A N/A N/A